Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Trial details
- Registry ID
- NCT05348200
- Drugs studied
- Combination - CITI-002 (high dose), Combination - CITI-002 (low dose), Monad 1, Monad 2 and 1 more
TrialRedline tracks 1 clinical trial sponsored by Citius Pharmaceuticals, Inc.: 1 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade HemorrhoidsNCT05348200 | Combination - CITI-002 (high dose), Combination - CITI-002 (low dose), Monad 1, Monad 2 and 1 more | Completed | 2023-04-20Actual |
Names as written in the registry records.